Skip to main content
Fig. 3 | Behavioral and Brain Functions

Fig. 3

From: Naringin provides neuroprotection in CCL2-induced cognition impairment by attenuating neuronal apoptosis in the hippocampus

Fig. 3

Naringin ameliorates recognition memory of CCL2–administered rats in novel object recognition. Effects of Naringin on cognitive function in CCL2-Induced rats was evaluate by novel object recognition test. a The discrimination index among group. CCL2 group rats showed significant lower discrimination index compared with the Naringin treatment groups. b The discrimination index of individual of each group. Naringin treatment groups rats spent more time to explore the novel object when compared to CCL2 group. Values are expressed as mean ± SEM, control group, sham group, Positive drug group, memantine group, Naringin low dose group, Naringin middle dose group, Naringin high dose group: n = 8; CCL2 group: n = 7 (#P < 0.05, ##P < 0.01 vs sham, *P < 0.05, **P < 0.01 vs CCL2)

Back to article page